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Abstract
Background. Epidemic models of sexually transmitted infections (STIs) are often used to characterize the
contribution of risk groups to overall transmission by projecting the transmission population attributable
fraction (tPAF) of unmet prevention and treatment needs within risk groups. However, evidence suggests
that STI risk is dynamic over an individual’s sexual life course, which manifests as turnover between risk
groups. We sought to examine the mechanisms by which turnover influences modelled projections of the
tPAF of high risk groups. Methods. We developed a unifying, data-guided framework to simulate risk
group turnover in deterministic, compartmental transmission models. We applied the framework to an illus-
trative model of an STI and examined the mechanisms by which risk group turnover influenced equilibrium
prevalence across risk groups. We then fit a model with and without turnover to the same risk-stratified
STI prevalence targets and compared the inferred level of risk heterogeneity and tPAF of the highest risk
group projected by the two models. Results. The influence of turnover on group-specific prevalence was
mediated by three main phenomena: movement of previously high risk individuals with the infection into
lower risk groups; changes to herd immunity in the highest risk group; and changes in the number of part-
nerships where transmission can occur. Faster turnover led to a smaller ratio of STI prevalence between
the highest and lowest risk groups. Compared to the fitted model without turnover, the fitted model with
turnover inferred greater risk heterogeneity and consistently projected a larger tPAF of the highest risk
group over time. Implications. If turnover is not captured in epidemic models, the projected contribution
of high risk groups, and thus, the potential impact of prioritizing interventions to address their needs, could
be underestimated. To aid the next generation of tPAF models, data collection efforts to parameterize risk
group turnover should be prioritized.
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Highlights
1. A new framework for parameterizing turnover in risk groups is developed
2. Mechanisms by which turnover influences STI prevalence in risk groups are examined
3. Turnover reduces the ratio of equilibrium STI prevalence in high vs low risk groups
4. Inferred risk heterogeneity is higher when fitting transmission models with turnover
5. Ignoring turnover in risk could underestimate the tPAF of high risk groups
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1. Introduction
Heterogeneity in transmission risk is a consistent characteristic of epidemics of sexually transmitted
infections (STI) [2]. This heterogeneity is often demarcated by identifying specific populations whose risks
of acquisition and onward transmission of STI are the highest, such that their specific unmet prevention
and treatment needs can sustain local epidemics of STI [44]. Disproportionate risk can be conferred in
several ways at the individual-level (higher number of sexual partners), partnership-level (reduced condom
use within specific partnership types), or structural-level (stigma as a barrier to accessing prevention and
treatment services) [4]. The contribution of high risk groups to the overall epidemic can then be used as an
indicator in the appraisal of STI epidemics, helping to guide intervention priorities [39, 34].
Traditionally, contribution to an epidemic was quantified using either: the classic population attributable
fraction (PAF) via the relative risk of incident infections within a risk group versus the rest of the population
and the relative size of the risk group [17]; or the distribution of new infections across subsets of a population
[8, 33]. So when small risk groups experience disproportionately higher rate of incident infections – e.g. 5
percent of a population acquire 30 percent of STI infections – contribution is interpreted as 5 percent of the
population contributing to 30 percent of all infections [38]. However, the classic PAF does not account for
chains of (indirect) transmission, and has been shown to underestimate the contribution of some higher-risk
groups to cumulative STI infections, especially over time [33]. Thus, transmission models are increasingly
being used to quantify contribution by accounting for indirect transmission and projecting the transmission
population attributable fraction (tPAF). The tPAF is calculated by simulating counterfactual scenarios where
transmission between specific subgroups is stopped, and the relative difference in cumulative infections in
the total population over various time-periods is measured [33, 35]. Transmission can be stopped by setting
susceptibility and/or infectiousness to zero in the model [33]. The tPAF is then interpreted as the fraction of
all new infections that stem, directly and indirectly, from a failure to prevent acquisition and/or to provide
effective treatment in a particular risk group [34, 35, 28].
There is limited evidence on how model structure might influence the tPAF of higher risk groups [34,
35, 28], especially movement of individuals between risk groups, an epidemiologic phenomenon that is well-
described in the context of sexual behaviour [43]. Such movement is often referred to in the STI epidemiology
literature as turnover [43]. For example, turnover may reflect entry into or retirement from formal sex work,
or other periods associated with higher STI susceptibility and onward transmission due to more partners
and/or vulnerabilities [30, 43]. Risk group turnover has been shown to influence the predicted equilibrium
prevalence of an STI [40, 45]; the fraction of transmissions occurring during acute HIV infection [45]; the
basic reproductive number R0 [18]; and the coverage of antiretroviral therapy required to achieve HIV
epidemic control [18]. Yet how, and the extent to which, turnover influences tPAF has yet to be examined.
There is variability in how turnover has been previously implemented [40, 23, 11, 7], in large part because
of four main assumptions or epidemiologic constraints surrounding movement between risk groups. For
example, in the context of turnover, the relative size of specific populations in the model may be constrained
to remain constant over time [40, 23, 11], such as the proportion of individuals who sell sex. Second, some
individuals may enter into high risk groups at an early age, and subsequently settle into lower risk groups;
thus the distribution of risks among individuals entering into the transmission model may be assumed to
be different from the distribution of risks among individuals already in the transmission model [11]. Third,
turnover may be constrained to reflect the average duration of time spent within a given risk group [7], such
as duration engaged in formal sex work [43]. Finally, turnover could reflect data on how sexual behaviour
changes following exit from a given risk group [7]. Most prior models used some combination of these
constraints, based on their specific data or research question, but to date there is no unified approach to
modelling turnover.
In this study, we explored the mechanisms by which turnover may influence the tPAF of a high risk group
using an illustrative STI model with treatment-induced immunity and without STI-attributable mortality.
First, we developed a unified approach to implementing turnover based on epidemiologic constraints. We
then sought the following objectives: 1) understand the mechanisms by which turnover influences group-
specific STI prevalence and ratios of prevalence between risk groups; 2) examine how inclusion/exclusion of
turnover in a model influences the level of risk heterogeneity inferred during model fitting; and 3) examine
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Figure 1: System of G = 3 risk groups and turnover between them.
xi: number of individuals in risk group i; ei: number of individuals available to enter risk group i; ν: rate of population entry;
µ: rate of population exit; φij : rate of turnover from group i to group j.
how inclusion/exclusion of turnover in a model influences the projected tPAF of the highest risk group after
model fitting to a particular setting.
2. Methods
We developed a new, unified framework for implementing turnover. We then simulated a deterministic
compartmental model of an illustrative STI, with turnover as per the framework, to conduct out experiments.
2.1. A unified framework for implementing turnover
We developed a framework for implementing turnover, as depicted in Figure 1 and detailed in Ap-
pendix A. In the framework, the simulated population is divided into G risk groups. The number of
individuals in group i ∈ [1, . . . , G] is denoted xi, and the relative size of each group is denoted xˆi = xi/N ,
where N is the total population size. Individuals enter the population at a rate ν and exit at a rate µ per
year. The distribution of risk groups at entry into the model is denoted eˆi, which may be different from xˆi.
The total number of individuals entering group i per year is therefore given by νeˆiN . Turnover rates are
collected in a G×G matrix φ, where φij is the proportion of individuals in group i who move from group i
into group j each year. The framework is independent of the disease model, and thus transition rates φ do
not depend on health states.
The framework assumes that: 1) the relative sizes of risk groups xˆ = [xˆ1, . . . , xˆG] are known and should
remain constant over time; and 2) the rates of population entry ν and exit µ are known, but that they
may vary over time. An approach to estimate ν and µ is detailed in Appendix A.2.1. The framework then
provides a method to estimate the values of the parameters eˆ and φ, representing G and G(G − 1) = G2
total unknowns. In the framework, eˆ and φ are collected in the vector θ = [eˆ,y], where y = veci6=j(φ). To
uniquely determine the elements of θ, a set of linear constraints are constructed. Each constraint k takes
the form bk = Akθ, where bk is a constant and Ak is a vector with the same length as θ. The values of θ
are then obtained by solving:
b = Aθ (1)
using existing algorithms for solving linear systems [25].
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Table 1: Summary of constraint types for defining risk group turnover
Constraint Assumption Parameters Types of data sources for parameterization
1. Constant group size the relative population sizes of groups
are known or assumed, and assumed
to not change over time
xˆi demographic health surveys [41], key popula-
tion mapping and enumeration [1]
2. Specified elements the relative numbers of people enter-
ing into each group upon entry into
the model or after leaving another
group are known or assumed
eˆi, φij demographic health surveys [41], key popula-
tion surveys [5]
3. Group duration the average durations of individuals in
each group are known or assumed
δi cohort studies of sexual behaviour over time
[14], key population surveys [43, 5]
4. Turnover rate ratios ratios between different rates of
turnover are known or assumed
φij demographic health surveys [41], key popula-
tion surveys [5]
φij : rate of turnover from group i to group j; xˆi: proportion of individuals in risk group i; eˆi: proportion of individuals entering
into risk group i; δi: average duration spent in risk group i.
S I Tλ τ
Figure 2: Modelled health states: S: susceptible; I: infected; T : treated; and transitions: λ: force of infection; τ : treatment.
The framework defines four types of constraints, which are based on assumptions, that can used to solve
for the values of eˆ and φ via θ. The frameworks is flexible with respect to selecting and combining these
constraints, guided by the availability of data. However, exactly G2 non-redundant constraints must be
specified to produce a unique solution, such that exactly one value of θ satisfies all constraints. Table 1
summarizes the four types of constraints, with their underlying assumptions, and the types of data that can
be used in each case. Additional details, including constraint equations, examples, and considerations for
combining constraints, are in Appendix A.2.2.
2.2. Transmission model
We developed a deterministic, compartmental model of an illustrative sexually transmitted infection
with 3 risk groups. We did not simulate a specific pathogen, but rather constructed a biological system
that included susceptible, infectious, and treated (or recovered/immune) health states. The transmission
model therefore was mechanistically representative of sexually transmitted infections like HIV, where ef-
fective antiretroviral treatment represents a health state where individuals are no longer susceptible nor
infectious [27], or hepatitis B virus, where a large proportion of individuals who clear their acute infection
develop life-long protective immunity [15].
The model is represented by a set of coupled ordinary differential equations (Appendix B.1) and includes
three health states: susceptible S, infectious I, and treated T (Figure 2), and G = 3 levels of risk: high H,
medium M , and low L. Risk strata are defined by different number of partners per year, so that individuals
in risk group i are assumed to form partnerships at a rate Ci per year. The probability of partnership
formation ρik between individuals in group i and individuals in risk group k is assumed to be proportionate
to the total number of available partnerships within each group [16]:
ρik =
Ckxk∑
k Ckxk
(2)
The biological probability of transmission is defined as β per partnership. Individuals transition from
the susceptible S to infectious I health state via a force of infection λi per year, per susceptible in risk
group i:
λi = Ci
∑
k
ρik β
Ik
xk
(3)
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Table 2: Default model parameters for experiments
Symbol Description Default value
β transmission probability per partnership 0.03
τ rate of treatment initiation among infected 0.1
N0 initial population size 1000
xˆ proportion of system individuals by risk group [0.05 0.20 0.75]
eˆ proportion of entering individuals risk by risk group [0.05 0.20 0.75]
δ average duration spent in each risk group [5 15 25]
C number of partners per year by individuals in each risk group [25 5 1]
ν rate of population entry 0.05
µ rate of population exit 0.03
All rates have units year−1; durations are in years; parameters stratified by risk group are written [high, medium, low] risk.
Individuals are assumed to transition from the infectious I to treated T health state at a rate τ per year,
reflecting diagnosis and treatment. The treatment rate does not vary by risk group. Individuals in the
treated T health state are neither infectious nor susceptible, and individuals cannot become re-infected.
2.2.1. Implementing turnover within the transmission model
As described in Section 2.1, individuals enter the model at a rate ν, exit the model at a rate µ, and
transition from risk group i to group j at a rate φij , health state. The turnover rates φ and distribution of
individuals entering the model by risk group eˆ were computed using the methods outlined in Appendix A.2.2,
based on the following three assumptions. First, we assumed that the proportion of individuals entering
each risk group eˆ was equal to the proportion of individuals across risk groups in the model xˆ. Second, we
assumed that the average duration of time spent in each risk group δ was known. Third, we assumed that the
absolute number of individuals moving between two risk groups in either direction was balanced, meaning
that if 10 individuals moved from group i to group j, then another 10 individuals moved from group j to
group i. These three assumptions were selected because they reflect the common assumptions underlying
turnover in prior models [45, 18] and also to avoid any dominant direction of turnover. That is, we wanted
to study the influence of movement between risk groups in general, as compared to no movement, and at
various rates of movement, rather than movement predominantly from some groups to some other groups.
The system of equations formulated from the above assumptions and constraints is given in Appendix B.2.
To satisfy all three assumptions, there was only one possible value for each element in φ and eˆ. That is, by
specifying these three assumptions, we generated a unique set of φ and eˆ.
Under the above three assumptions, we still needed to specify the particular values of the parameters
xˆ, δ, ν, and µ. Such parameter values could be derived from data as described in Appendix A.2.2. However,
in all our experiments, we used the illustrative values summarized in Table 2. After resolving the system of
equations Eq. (1) using these values, eˆ was equal to xˆ (assumed), and φ was:
φ =
 ∗ 0.0833 0.08670.0208 ∗ 0.0158
0.0058 0.0042 ∗
 (4)
We then simulated epidemics using φ above and the parameters shown in Table 2. The transmission
model was initialized with N0 = 1000 individuals who were distributed across risk groups according to xˆ.
We seeded the epidemic with one infectious individual in each risk group at t = 0 in an otherwise fully
susceptible populatuon. We numerically solved the system of ordinary differential equations (Appendix B.1)
in Python using Euler’s method with a time step of dt = 0.1 years. Code for all aspects of the project is
available at: https://github.com/mishra-lab/turnover.
2.3. Experiments
We designed three experiments to examine the influence of turnover on simulated epidemics. We analyzed
all outcomes at equilibrium, defined as steady state at t = 500 years with < 1% change in incidence per
year.
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Figure 3: Average duration of time spent in each risk group versus turnover.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
2.3.1. Experiment 1: Mechanisms by which turnover influences equilibrium prevalence
We designed Experiment 1 to explore the mechanisms by which turnover influences the equilibrium STI
prevalence of infection, and the ratio of prevalence between risk groups (prevalence ratios). We defined
prevalence as Iˆi = Ii
xi
. Similar to previous studies [45, 18], we varied the rates of turnover using a single
parameter. However, because our model had G = 3 risk groups, multiplying a set of base rates φ by a scalar
factor would change the relative population sizes of risk groups xˆ. Instead of a scalar factor, we controlled
the rates of turnover using the duration of time spent in the high risk group δH , because of the practical
interpretation of δH in the context of STI transmission, such as the duration in formal sex work [43]. A
shorter δH yielded faster rates of turnover among all groups. The duration of time spent in the medium risk
group δM was then defined as a value between δH and the maximum duration µ
−1 which scaled with δH
following: δM = δH + κ
(
µ−1 − δH
)
, with κ = 0.3. The duration of time in the low risk group δL similarly
scaled with δH , but due to existing constraints, specification of δH and δM ensured only one possible value
of δL. Thus, each value of δH yielded a unique set of turnover rates φ whose elements all scaled inversely
with the duration in the high risk group δH .
We varied δH across a range of 33 to 3 years, reflecting a range from the full duration of simulated
sexual activity µ−1 ≈ 33 years, through an average reported duration in sex work as low as 3 years [43].
The resulting duration of time spent in each group versus turnover in the high risk group δ−1H is shown in
Figure 3. For each set of turnover rates, we plotted the equilibrium prevalence in each risk group, and the
prevalence ratios between high/low, high/medium, and medium/low risk groups. In order to understand the
mechanisms by which turnover influenced prevalence and prevalence ratios (Objective 1), we additionally
plotted the four components which contributed to gain/loss of infectious individuals in each risk group,
based on Eq. (B.1b): 1) net gain/loss via turnover of infectious individuals, 2) gain via incident infections,
3) loss via treatment, and 4) loss via death. The influence of turnover on prevalence was only mediated
by components 1 and 2, since components 3 and 4 were defined as constant rates which did not change
with turnover; as such, our analysis focused on components 1 and 2. Finally, to further understand trends
in incident infections versus turnover (component 1), we factored equation Eq. (3) for incidence λi into
constant and non-constant factors, and plotted the non-constant factors versus turnover.
2.3.2. Experiment 2: Inferred risk heterogeneity with vs without turnover
We designed Experiment 2 to examine how the inclusion versus exclusion of turnover influences the
inference of transmission model parameters related to risk heterogeneity, specifically the numbers of partners
per year Ci across risk groups. The ratio of partner numbers CH / CL is one way to measure of how different
the two risk groups are with respect to acquisition and transmission risks. Indeed, ratios of partner numbers
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are often used when parameterizing risk heterogeneity in STI transmission models [32].
First, we fit the transmission model with turnover and without turnover, to equilibrium infection preva-
lence across risk groups. Specifically, we held all other parameters at their default values and fit the numbers
of partners per year in each risk group Ci to reproduce the following: 20% infection prevalence among the
high risk group, 8.75% among the medium risk group, 3% among the low risk group, and 5% overall. To
identify the set of parameters (i.e. partner numbers C in each risk group) that best reproduced the fitting
targets, we minimized the negative log-likelihood of group-specific and overall prevalence. Sample sizes of
500, 2000, 7500, and 10,000 were assumed to generate binomial distributions for the high, medium, low,
and overall prevalence targets respectively, reflecting typical sample sizes in nationally representative de-
mographic and health surveys [41], multiplied by the relative sizes of risk groups in the model xˆ. The
minimization was performed using the SLSQP method [24] from the SciPy Python minimize package. To
address Objective 2, we compared the fitted (posterior) ratio of partners per year CH / CL in the model
with turnover versus the model without turnover.
2.3.3. Experiment 3: Influence of turnover on the tPAF of the high risk group
We designed Experiment 3 to examine how the tPAF of the high risk group varies when projected by a
model with versus without turnover (Objective 3). We calculated the tPAF of risk group i by comparing the
relative difference in cumulative incidence between a base scenario, and a counterfactual where transmission
from group i is turned off, starting at the fitted equilibrium. That is, in the counterfactual scenario, infected
individuals in the high risk group could not transmit the infection. The tPAF was calculated over different
time-horizons (1 to 50 years) as [33]:
tPAFi(t) =
∫ t
teq
Ib(τ) dτ −
∫ t
teq
Ic(τ) dτ∫ t
teq
Ib(τ) dτ
(5)
where teq is the time corresponding to equilibrium, Ib(t) is the rate of new infections at time t in the base
scenario, and Ic(t) is the rate of new infections at time t in the counterfactual scenario. We then compared
the tPAF generated from the fitted model with turnover to the tPAF generated from the fitted model
without turnover.
3. Results
3.1. Experiment 1: Mechanisms by which turnover influences equilibrium prevalence
Figure 4 shows the trends in equilibrium STI prevalence among the high (a), medium (b), and low (c) risk
groups, at different rates of turnover which are depicted on the x-axis, based on duration of time spent in the
high risk group. Figure 4 reveals an inverted U-shaped relationship between STI prevalence and turnover
in all three risk groups. That is, equilibrium STI prevalence was higher in systems with slow turnover
versus those with no turnover (Figure 4, region A). Equilibrium STI prevalence then peaked at slightly
faster turnover before declining in systems with even faster turnover (region B in Figure 4). Comparison
of group-specific prevalence in Figure 4 shows that the threshold turnover rate at which group-specific
prevalence peaked varied by risk group: prevalence in the high risk group peaked at the lower turnover
threshold (Figure 4a), while prevalence in low risk group peaked at a higher turnover threshold (Figure 4c).
To explain the inverted U-shape and different turnover thresholds by group, we examined the components
contributing to prevalence, first in the high risk group, and then in the low risk group.
Figure 5 shows the yearly gain/loss of individuals via turnover, and gain/loss via incident infections, in
each health state and risk group, at equilibrium under different rates of turnover. Figure 6 also illustrates
the distribution of health states in each risk group and among individuals moving between risk groups under
four different rates of turnover.
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Figure 4: Relationship between equilibrium STI prevalence in high, medium, and low risk groups versus turnover rate. Regions
A and B denote where equilibrium prevalence is increasing and decreasing with different rates of turnover, respectively.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
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(c) High risk treated
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(e) Low risk infectious
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Figure 5: Absolute rates of change at equilibrium (number of individuals gained/lost per year) among individuals in each health
state and risk group, due to: loss/gain via turnover (yellow), and loss/gain via incident infections (red). Based on Eq. (B.1).
See Figure C.2 for all derivative components.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
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δ−1H = 0.03
(b) Slow turnover
δ−1H = 0.062
(c) Fast turnover
δ−1H = 0.162
(d) Very fast turnover
δ−1H = 0.333︸ ︷︷ ︸
Region A
︸ ︷︷ ︸
Region B
Figure 6: Depiction of health states of individuals in each risk group and of individuals moving between risk groups, obtained
from models at equilibrium under four overall rates of turnover.
Circle sizes are proportional to risk group sizes. Circle slices and arrow widths are also proportional to the proportion of health
states within risk groups and among individuals moving between risk groups, respectively. However, circle sizes and arrow
widths do not have comparable scales. Appendix Figure C.1 illustrates proportions of health states versus turnover in full.
3.1.1. Influence of turnover on equilibrium prevalence in the high risk group
As shown in Figure 6, at all four rates of turnover the proportion of individuals who were in the infectious
state (STI prevalence) was largest in the high risk group. As infectious individuals left the high risk group
via turnover, they were largely replaced by susceptible individuals from lower risk groups (Figure 6b and
Figures 5a vs 5b, yellow). The pattern of net outflow of infectious individuals from the high risk group
via turnover persisted across the range of turnover rates (Figure 5b, yellow). This net outflow of infectious
individuals via turnover acted to reduce STI prevalence in the high risk group (phenomenon 1). Treated
individuals were similarly replaced largely by susceptible individuals (Figure 6b and Figures 5a vs 5c, yellow).
The net replacement of both infectious and treated individuals with susceptible individuals in the high risk
group acted to reduce herd immunity in that group. Reduced herd immunity then contributed to a rise in the
number of incident infections in the high risk group, as the system moved from no turnover to slow turnover
(Figure 5b, red; phenomenon 2). Incidence was further influenced by a third phenomenon as systems moved
from no turnover to higher rates of turnover: the net movement of infectious individuals from high to low risk
(Figure 6b) reduced the average number of partners per year made available by individuals in the infectious
state (Figure 7a). As shown in Appendix B.4, modelled incidence in all risk groups was proportional to
the average number of partners per year among infectious individuals (Figure 7a), and overall prevalence
(Figure 7b). Thus, as the average number of partners per year among infectious individuals fell with faster
turnover, incidence decreased (Figure 7c, region B; phenomenon 3).
Therefore, the inverted U-shaped relationship between turnover rate and equilibrium STI prevalence in
the high risk group was mediated by the combination of the above three phenomena. When systems moved
from no turnover to slow turnover, reduction in herd immunity (phenomenon 2) predominated, leading to
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Figure 7: Overall incidence and the non-constant factors of incidence versus turnover. The product of factors (a) and (b) is
proportional to (c) overall incidence. See Appendix B.4 for proof.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
increasing equilibrium prevalence with turnover (Figure 4a, region A). When systems were modelled under
faster and faster turnover, outflow of infectious individuals from the group via turnover (phenomenon 1)
and reduction in the average number of partners per year among infectious individuals (phenomenon 3)
predominated, leading to lower equilibrium prevalence at faster rates of turnover (Figure 4a, region B).
3.1.2. Influence of turnover on equilibrium prevalence in the low risk group
As shown in Figure 6, at equilibrium, the low risk group was composed mainly of susceptible individuals.
Moving from a system no turnover to one with slow turnover lead to a net inflow of infectious and treated
individuals (Figures 5e and 5f, yellow), and a net removal of susceptible individuals (Figure 5d, yellow). The
net inflow of infectious individuals (Figure 5e, yellow) contributed to higher equilibrium prevalence in the
low risk group when the system moved from no turnover to slow turnover (phenomenon 1). The inflow of
infectious and treated individuals only slightly reduced the already large proportion who were susceptible in
the low risk group. Thus, there was little increase in herd immunity within the low risk group as turnover
increased (phenomenon 2). However, incident infections still rose in the low risk group as the system moved
from no turnover to slow turnover (Figure 5e, red) due to higher incidence in the total population (Figure 7c)
which was largely driven by reduced herd immunity in the high risk group (see Section 3.1.1; phenomenon 2).
Under faster rates of turnover, incident infections declined in the low risk group (Figure 5e, red) due to lower
incidence in the total population (Figure 7c) which was driven by decreasing number of partners per year
among infectious individuals (Figure 7a; phenomenon 3), as described in Section 3.1.1.
Therefore, as in the high risk group, the inverted U-shaped relationship between turnover rate and
equilibrium STI prevalence in the low risk group was mediated by the combination of the above three phe-
nomena. Moving from no turnover to slow turnover, the net inflow of infectious individuals (phenomenon 1)
and reduced herd immunity in the high risk group (phenomenon 2) predominated, leading to higher equi-
librium prevalence (Figure 4c, region A). At higher rates of turnover, a decreasing overall incidence due to
a reduction in the number of partners among infectious individuals (phenomenon 3) predominated, leading
to declining equilibrium prevalence (Figure 4c, region B).
In sum, there were three phenomena that drove shifts in equilibrium STI prevalence across risk groups
at variable rates of turnover: 1) net flows of infectious individuals from high risk groups into low risk
groups; 2) changes to herd immunity, especially within the high risk group; and 3) changes to the number
of partnerships available with infectious individuals.
3.1.3. Influence of turnover on STI prevalence ratio between high and low risk groups
As discussed in Sections 3.1.1 and 3.1.2, turnover caused a net outflow of infectious individuals from
the high risk group (Figure 5b, yellow) and a net inflow of infectious individuals into the low risk group
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Figure 8: Equilibrium prevalence ratios between high and low risk groups under different rates of turnover.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
(Figure 5e, yellow). In contrast, the influence of turnover on the rate of incident infections followed a more
similar pattern in both the high and low risk groups (Figures 5b and 5e, red). Therefore, differences in the
influence of turnover on prevalence between risk groups were driven by net movement of infectious individuals
from high to low risk, causing prevalence in the high and low risk groups to come closer together with faster
turnover. As shown in Figure 8, the ratio of equilibrium STI prevalence in the high versus low risk groups
was thus reduced under faster turnover rates. For example, the prevalence ratio between high and low risk
groups was: 6.7 in the model under high turnover (δH = 5 years) versus 9.2 in the model without turnover
(δH = 33 years) (Table 3). Finally, the propensity for equilibrium STI prevalence to decrease in the high
risk group and for prevalence to increase in the low risk group with faster turnover (due to net movement of
infectious individuals from high to low risk) also explains why prevalence peaked at slower turnover in the
high risk group (Figure 4a) and faster turnover in the low risk group (Figure 4c).
3.2. Experiment 2: Inferred risk heterogeneity with versus without turnover
After model fitting, our two STI transmission models (one with turnover and one without turnover)
reproduced the target equilibrium STI prevalence values of 20%, 8.75%, 3%, and 5% in the high, medium,
low risk groups, and total population, respectively (Table 3; Figure C.7). When fitting the model with
turnover to these group-specific prevalence targets, the fitted numbers of partners per year Ci (the only
non-fixed parameter) had to compensate for the reduction in STI prevalence ratio between high and low
risk groups (Figure 8). As a result, the ratio of fitted partner numbers between high and low risk groups
(CH / CL) had to be higher in the model with turnover compared to the model without turnover: 23.9 vs 15.2
(Table 3). That is, the inferred level of risk heterogeneity was higher in the model with turnover than in
the model without turnover.
3.3. Experiment 3: Influence of turnover on the tPAF of the high risk group
Finally, we compared the tPAF of the high risk group projected by the fitted model with turnover and
the fitted model without turnover (Figure 9). The tPAF projected by both models increased over longer
and longer time horizons, indicating that unmet prevention and treatment needs of the high risk group were
central to epidemic persistence in both fitted models. The model with turnover projected a larger tPAF
at all time-horizons compared with the tPAF projected by the model without turnover. The larger tPAF
projected by the model with turnover stemmed from more risk heterogeneity (Table 3) which led to more
onward transmission from the unmet prevention and treatment needs of the high risk group.
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Table 3: Equilibrium partnership formation rates and prevalence among the high and low risk groups predicted by the models
with and without turnover, before and after model fitting.
Number of Partners Prevalence
Context High Low High/Low High Low High/Low
Turnover 25.0 1.0 25.0 21.6% 3.2% 6.7
No Turnover 25.0 1.0 25.0 21.9% 2.4% 9.2
Turnover [fit] 24.3 1.0 23.9 20.0% 3.0% 6.7
No Turnover [fit] 23.5 1.5 15.2 20.0% 3.0% 6.7
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Figure 9: Transmission population attributable fraction (tPAF) of the high risk group in models with and without turnover,
after fitting the number of partners per year to group-specific prevalence.
4. Discussion
Using a mechanistic modelling analysis, we found that turnover could be important when projecting
the tPAF of high risk groups to the overall epidemic. Mechanistic insights include disentangling three key
phenomena by which turnover alters equilibrium STI prevalence within risk groups, and thereby the level of
inferred risk heterogeneity between groups via model fitting. Methodological contributions include a frame-
work for modelling turnover which uses a flexible combination of data-driven constraints. Taken together,
our explanatory insights and framework have mechanistic, public health, and methodological relevance for
the parameterization and use of epidemic models to project intervention priorities for high risk groups.
Influence of turnover on prevalence. Building on prior work by Stigum et al. [40], Zhang et al. [45], Henry
and Koopman [18] which similarly found an inverted U-shaped relationship between turnover and overall
equilibrium STI prevalence, we identified three key phenomena that generated this relationship. These
turnover-driven phenomena were: 1) a net flow of infectious individuals from higher risk groups to lower
risk groups; 2) reduced herd immunity in the higher risk groups due to net gain of susceptible individuals;
and 3) reduced incidence overall due to fewer partner numbers among infectious individuals. The above
three phenomena contributed to the pattern of declining prevalence ratio between the highest and lowest
risk groups for increasing rates of turnover. A decline in prevalence ratio due to turnover implies a reduction
in risk heterogeneity. Since risk heterogeneity is associated with epidemic emergence and persistence [31]
– i.e. the basic reproductive number – our findings are thus consistent with Henry and Koopman [18],
who demonstrated that turnover reduces the basic reproductive number by reducing heterogeneity. Indeed,
epidemiological and transmission modelling studies have shown that prevalence ratios are an important
marker of risk heterogeneity, and in turn the impact of interventions focused on high risk groups [3, 32].
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Implications for interventions. Our comparison of fitted models with and without turnover showed that if
turnover exists in a given setting but is ignored in a model, the inferred heterogeneity in risk would be lower
than in reality, while reproducing the same STI prevalence in each risk group. As a result, the projected
tPAF of high risk groups could be systematically underestimated by models that ignore turnover. Although
we examined a single parameter to capture risk (number of partners per year), the findings would hold for any
combination of factors that alter the risk per susceptible individual (force of infection), including biological
transmission probabilities and rates of partner change [2]. The public health implications of models ignoring
turnover, and thereby underestimating risk heterogeneity and the tPAF of high risk groups, is that resources
could potentially be misguided away from high risk groups. For example, epidemic models which fail to
include or accurately capture turnover may underestimate the importance of addressing the unmet needs of
key populations at disproportionate risk of HIV and other STIs, such as gay men and other men who have
sex with men, transgender women, people who use drugs, and sex workers. In many HIV epidemic models
of regions with high HIV prevalence, such as in Southern Africa, key populations have historically been
subsumed into the overall modelled population; which meant, by design, less risk heterogeneity [12, 9, 34].
Our findings suggest that even when key populations are included, it is important to further capture within-
person changes in risks over time (such as duration in sex work). Underestimating risk heterogeneity could
also underestimate the resources required to achieve local epidemic control, as suggested by Henry and
Koopman [18], Hontelez et al. [19]. Important next steps surrounding the potential bias in tPAF projections
attributable to inclusion/exclusion of turnover include quantifying the magnitude of bias, and characterizing
the epidemiologic conditions under which the bias would be meaningfully large in the context of public health
programmes.
Turnover framework. We developed a unified framework to parameterize risk group turnover using available
epidemiologic data and/or assumptions. There are four potential benefits of using the framework to model
turnover. First, the framework defines how specific epidemiologic data and assumptions could be used as
constraints to help define rates of turnover. Second, the framework allows flexibility in which constraints
can be chosen and combined, so that the constraints best reflect locally available data and/or plausible
assumptions. In fact, the framework can adequately reproduce several prior implementations of turnover
in various epidemic models [40, 11, 18]. Third, this flexible approach also allows the framework to scale
to any number of risk groups. Finally, the framework avoids the need for a burn-in period to establish a
demographic steady-state before introducing infection, which was required in some previous models [7].
As noted above, one benefit of the unified framework for modelling turnover is clarifying data priorities for
parameterizing turnover. Absolute or relative population size estimates across risk groups may be obtained
from population-based sexual behaviour surveys [41], and from mapping and enumeration of marginalized
persons such as sex workers [1]. The proportion of individuals who enter into each risk group may be
available through sexual behaviour surveys: for example, among individuals who became sexually active for
the first time in the past year, the proportion who also engaged in multiple partnerships within the past
year. The average duration of time spent within each risk group, such as the duration in sex work, may
be drawn from cross-sectional survey questions such as “for how many years have you been a sex worker?”
albeit with the recognition that such data are censured [43]. Longitudinal, or cohort studies that track
self-reported sexual behaviour over time can also provide estimates of duration of time spent within a given
risk strata [14], or provide direct estimates of transition rates between risk strata.
Limitations. Our framework for modelling turnover was developed specifically to answer mechanistic ques-
tions about the tPAF; as such, there are two key limitations of the framework in its current form. First,
the framework did not stratify the population by sex or age. In the context of real-world STI epidemics,
the relative size of risk groups may differ by both sex and age, such as the often smaller number of fe-
males and/or males who sell sex, versus the larger number of males who pay for sex (clients of female or
male sex workers). Second, the framework does not account for infection-attributable mortality, such as
HIV-attributable mortality. However, modelling studies have shown that HIV-attributable mortality can
reduce the relative size of higher risk groups who bear a disproportionate burden of HIV, which in turn
can cause an HIV epidemic to decline [6]. As such, many models of HIV transmission that include very
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small (< 3% of the population) high risk groups, such as female sex workers, often do not constrain the
relative size of the sub-group populations to be stable over time [36]. By ignoring infection-attributable
mortality, the proposed framework would similarly allow risk groups to change relative size in response to
disproportionate infection-attributable mortality. Future modifications of the proposed framework include
methods to optionally re-balance infection-attributable mortality, and relevant age-sex stratifications so that
the framework can be applied more broadly to pathogen-specific epidemics.
Our analyses of turnover and tPAF also have several limitations. First, we did not capture the possibility
that some individuals may become re-susceptible to infection after treatment – an important feature of many
STIs such as syphilis and gonorrhoea [13]. As shown by Fenton et al. [13] and Pourbohloul et al. [37], the
re-supply of susceptible individuals following STI treatment could fuel an epidemic, and so the influence of
turnover on STI prevalence and tPAF may be different. Second, our analyses were restricted to equilibrium
STI prevalence. The influence of turnover on prevalence and tPAF may vary within different phases of an
epidemic – growth, mature, declining [42]. Finally, our analyses reflected an illustrative STI epidemic in
a population with illustrative risk strata. Important next steps in the examination of the extent to which
turnover influences the tPAF include pathogen- and population-specific modelling – such as the comparisons
of model structures by Hontelez et al. [19], Johnson and Geffen [21] – and at different epidemic phases.
Conclusion. In conclusion, turnover may influence prevalence of infection, and thus influence inference on
risk heterogeneity when fitting risk-stratified epidemic models. If models do not capture turnover, the
projected contribution of high risk groups, and thus, the potential impact of prioritizing interventions to
meet their needs, could be underestimated. To aid the next generation of epidemic models used to estimate
the tPAF of high risk groups – including key populations – data collection efforts to parameterize risk group
turnover should be prioritized.
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A. Turnover Framework
We introduce a system of parameters and constraints to describe risk group turnover in deterministic
epidemic models with heterogeneity in risk.1 We then describe how the system can be used in practical
terms, based on different assumptions and data available for parameterizing turnover in risk. We conclude
by framing previous approaches to this task using the proposed system.
A.1. Notation
Consider a population divided into G risk groups. We denote the number of individuals in risk group
i ∈ [1, . . . , G] as xi and the set of all risk groups as x = {x1, . . . , xG}. The total population size is N =
∑
i xi,
and the relative population size of each group is denoted as xˆi = xi/N . Individuals enter the population at
a rate ν per year, and exit at a rate µ per year. We model the distribution of risk groups among individuals
entering into the population as eˆ, which may be different from individuals already in the population xˆ.2
Thus, the total number of individuals entering into population x per year is given by νN , and the number
of individuals entering into group i specifically is given by eˆiνN .
Turnover transitions may then occur between any two groups, in either direction. Therefore we denote
the turnover rates as a G × G matrix φ. The element φij corresponds to the proportion of individuals in
group i who move from group i to group j each year. An example matrix is given in Eq. (A.1), where we
write the diagonal elements as ∗ since they represent transitions from a group to itself.
φ =

∗ x1 → x2 · · · x1 → xG
x2 → x1 ∗ · · · x2 → xG
...
...
. . .
...
xG → x1 xG → x2 · · · ∗
 (A.1)
Risk groups, transitions, and the associated rates are also shown for G = 3 in Figure A.1.
A.2. Parameterization
Next, we present methods to illustrate how epidemiologic data can be used to parametrize turnover in
epidemic models. We construct a system like the one above which reflects the risk group dynamics observed
in a specific context. We assume that the relative sizes of the risk groups in the model (xˆ) are already known,
and should remain constant over time. Thus, what remains is to estimate the values of the parameters: ν,
µ, eˆ, and φ, using commonly available sources of data.
A.2.1. Total Population Size
The total population size N(t) is a function of the rates of population entry ν(t) and exit µ(t), given
an initial size N0. We allow the proportion entering the system to vary by risk group via eˆ, while the exit
rate has the same value for each group. We assume that there is no disease-attributable death. Because the
values of ν and µ are the same for each risk group, they can be estimated independent of xˆ, eˆ, and φ.
The difference between entry and exit rates defines the rate of population growth:
G(t) = ν(t)− µ(t) (A.2)
The total population may then be defined using an initial population size N0 as:
N(t) = N0 exp
(∫ t
0
log
(
1 + G(τ))dτ) (A.3)
1 A preliminary version of this framework was used by Knight et al. [22].
2 We could equivalently stratify the rate of entry ν by risk group; however, we find that the mathematics in subsequent sections
are more straightforward using eˆ.
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Figure A.1: System of G = 3 risk groups and turnover between them.
xi: number of individuals in risk group i; ei: number of individuals available to enter risk group i; ν: rate of population
entry; µ: rate of population exit; φij : rate of turnover from group i to group j.
which, for constant growth, simplifies to the familiar expression [29]:
N(t) = N0(1 + G)t (A.4)
Census data, such as [10], can be used to source the total population size in a given geographic setting over
time N(t), thus allowing Eqs. (A.3) and (A.4) to be used to estimate G(t).
If the population size is assumed to be constant, then G(t) = 0 and ν(t) = µ(t). If population growth
occurs at a stable rate, then G is fixed at a constant value which can be estimated via Eq. (A.4) using any
two values of N(t), separated by a time interval τ :
Gτ = N(t+ τ)
N(t)
1
τ
− 1 (A.5)
If the rate of population growth G varies over time, then Eq. (A.5) can be reused for consecutive time
intervals, and the complete function G(t) approximated piecewise by constant values. The piecewise approx-
imation can be more feasible than exact solutions using Eq. (A.3), and can reproduce N(t) accurately for
small enough intervals τ , such as one year.
Now, given a value of G(t), either ν(t) must be chosen and µ(t) calculated using Eq. (A.2), or µ(t) must
be chosen, and ν(t) calculated. Most modelled systems assume a constant duration of time that individuals
spend in the model δ(t) [2] which is related to the rate of exit µ by:
δ(t) = µ−1(t) (A.6)
In the context of sexually transmitted infections, the duration of time usually reflects the average sexual
life-course of individuals from age 15 to 50 years, such that δ = 35 years. The duration δ may also vary
with time to reflect changes in life expectancy. The exit rate µ(t) can then be defined as δ−t(t) following
Eq. (A.6), and the entry rate ν(t) defined as G(t)− µ(t) following Eq. (A.2).
A.2.2. Turnover
Next, we present methods for resolving the distribution of individuals entering the risk model eˆ(t) and
the rates of turnover φ(t), assuming that entry and exit rates ν(t) and µ(t) are known. Similar to above, we
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first formulate the problem as a system of equations. Then, we explore the data and assumptions required
to solve for the values of parameters in the system. The (t) notation is omitted throughout this section for
clarity, though time-varying parameters can be estimated by repeating the necessary calculations for each t.
The number of risk groups G dictates the number of unknown elements in eˆ and φ: G and G(G − 1),
respectively. We collect these unknowns in the vector θ = [eˆ,y], where y = veci 6=j(φ). For example, for
G = 3, the vector θ is defined as:
θ =
[
eˆ1 eˆ2 eˆ3 φ12 φ13 φ21 φ23 φ31 φ32
]
(A.7)
We then define a linear system of equations which uniquely determine the elements of θ:
b = Aθ (A.8)
where A is a M×G2 matrix and b is a M -length vector. Specifically, each row in A and b defines a constraint:
an assumed mathematical relationship involving one or more elements of eˆ and φ. For example, a simple
constraint could be to assume the value eˆ2 = 0.20. Each of the following four sections introduces a type of
constraint, including: assuming a constant group size, specifying elements of θ directly, assuming an average
duration in a group, and specifying a relationship between two individual rates of turnover. Constraints may
be selected and combined together based on availability of data and plausibility of assumptions. However,
a total of M = G2 constraints must be defined in order to obtain a “unique solution”: exactly one value
of θ which satisfies all constraints. The values of eˆ and φ can then be calculated algebraically by solving
Eq. (A.8) with θ = A−1b, for which many algorithms exist [25].
1. Constant group size. One epidemiologic feature that epidemic models consider is whether or not the
relative sizes of risk groups are constant over time [18, 7]. Assuming constant group size implies a stable
level of heterogeneity over time. To enforce this assumption, we define the “conservation of mass” equation
for group i, wherein the rate of change of the group is defined as the sum of flows in / out of the group:
d
dt
xi = νNeˆi +
∑
j
φji xj − µxi −
∑
j
φij xi (A.9)
Eq. (A.9) is written in terms of absolute population sizes x, but can be written as proportions xˆ by dividing
all terms by N . If we assume that the proportion of each group xˆi is constant over time, then the desired rate
of change for risk group i will be equal to the rate of population growth of the risk group, Gxi. Substituting
d
dtxi = Gxi into Eq. (A.9), and simplifying yields:
ν xi = ν Neˆi +
∑
j
φji xj −
∑
j
φij xi (A.10)
Factoring the left and right hand sides in terms of eˆ and φ, we obtain G unique constraints. For G = 3, this
yields the following 3 rows as the basis of b and A:
b =
 νx1νx2
νx3
 ; A =
 ν · · −x1 −x1 x2 · x3 ·· ν · x1 · −x2 −x2 · x3
· · ν · x1 · x2 −x3 −x3
 (A.11)
These G constraints ensure risk groups do not change size over time. However, a unique solution requires
an additional G(G− 1) constraints. For G = 3, this corresponds to 6 additional constraints.
2. Specified elements. The simplest type of additional constraint is to directly specify the values of individual
elements in eˆ or φ. Such constraints may be appended to b and A as an additional row k using indicator
notation.3 That is, with bk as the specified value v, and Ak as the indicator vector, with 1 in the same
3 Indicator notation, also known as “one-hot notation” is used to select one element from another vector, based on its position.
An indicator vector is 1 in the same location as the element of interest, and 0 everywhere else.
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position as the desired element in θ:
bk = v; Ak = [0, . . . , 1, . . . , 0] (A.12)
For example, for G = 3, if it is known that 20% of individuals enter directly into risk group 2 upon entry
into the model (eˆ2 = 0.20), then b and A can be augmented with:
bk =
[
0.20
]
; Ak =
[ · 1 · · · · · · · ] (A.13)
since eˆ2 is the second element in θ. If the data suggest zero turnover from group i to group j, then Eq. (A.13)
can also be used to set φij = 0.
The elements of eˆ must sum to one. Therefore, specifying all elements in eˆ will only provide G − 1
constraints, as the last element will be either redundant or violate the sum-to-one rule. As shown in
Appendix B.3, the sum-to-one rule is actually implicit in Eq. (A.11), so it is not necessary to supply a
constraint like 1 =
∑
i eˆi.
3. Group duration. Type 1 constraints assume that the relative population size of each group remains
constant. Another epidemiologic feature that epidemic models considered is whether or not the duration
of time spent within a given risk group remains constant. For example, in STI transmission models that
include formal sex work, it can be assumed that the duration in formal sex work work remains stable over
time, such as in [33, 7]. The duration δi is defined as the inverse of all rates of exit from the group:
δi =
(
µ+
∑
j
φij
)−1
(A.14)
Estimates of the duration in a given group can be sourced from cross-sectional survey data where participants
are asked about how long they have engaged in a particular practice – such as sex in exchange for money
[43]. Data on duration may also be sourced from longitudinal data, where repeated measures of self-reported
sexual behaviour, or proxy measures of sexual risk data, are collected [41, 20]. Data on duration in each risk
group can then be used to define φ by rearranging Eq. (A.14) to yield: δi
−1 − µ = ∑j φij . For example, if
for G = 3, the average duration in group 1 is known to be δ1 = 5 years, then b and A can be augmented
with another row k:
bk =
[
5−1 − µ ] ; Ak = [ · · · 1 1 · · · · ] (A.15)
Similar to specifying all elements of eˆ, specifying δi may result in conflicts or redundancies with other
constraints. A conflict means it will not be possible to resolve values of φ which simultaneously satisfy all
constraints, while a redundancy means that adding one constraint does not help resolve a unique set of
values θ. For example, for G = 3, if Type 2 constraints are used to specify φ12 = 0.1 and φ13 = 0.1, and
µ = 0.05, then by Eq. (A.14), we must have δ1 = 4. Specifying any other value for δ1 will result in a conflict,
while specifying δ1 = 4 is redundant, since it is already implied. There are innumerable situations in which
this may occur, so we do not attempt to describe them all. Section A.2.2 describes how to identify conflicts
and redundancies when they are not obvious.
4. Turnover rate ratios. In many cases, it may be difficult to obtain estimates of a given turnover rate φij
for use in Type 2 constraints. However, it may be possible to estimate relative relationships between rates
of turnover, such as:
r φij = φi′j′ (A.16)
where r is a ratio relating the values of φij and φi′j′ . For example, for G = 3, let T1 be the total number
of individuals entering group 1 due to turnover. If we know that 70% of T1 originates from group 2, while
30% of T1 originates from group 3, then 0.7T1 = φ23 x2 and 0.3T1 = φ13 x1, and thus: φ23
(
0.3 x2
0.7 x1
)
= φ13.
This constraint can then be appended as another row k in b and A like:
bk =
[
0
]
; Ak =
[
· · · ·
(
0.3 x2
0.7 x1
)
· 1 · ·
]
(A.17)
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Table A.1: Summary of constraint types for defining risk group turnover
Name Eq. E.g. Data requirements
1. Constant group size (A.10) (A.11) all values of xˆi and ν
2. Specified elements (A.12) (A.13) any value of eˆi or φij
3. Group duration (A.14) (A.15) any value of δi
4. Turnover rate ratios (A.16) (A.17) any relationship between two turnover rates φij and φi′j′
ν: rate of population entry; φij : rate of turnover from group i to group j; xˆi: proportion of individuals in risk group i;
eˆi: proportion of individuals entering into risk group i; δi: average duration spent in risk group i.
The example in Eq. (A.17) is based on what proportions of individuals entering a risk group j came from
which former risk group i, but similar constraints may be defined based on what proportions of individuals
exiting a risk group i enter into which new risk group j. It can also be assumed that the absolute number
of individuals moving between two risk groups is equal, in which case the relationship is: φij
(
xi
xj
)
= φji.
All constraints of this type will have bk = 0.
Solving the System. Table A.1 summarizes the four types of constraints described above. Given a set of
sufficient constraints on θ to ensure exactly one solution, the system of equations Eq. (A.8) can be solved
using θ = A−1b. The resulting values of eˆ and φ can then be used in the epidemic model.
However, we may find that we have an insufficient number of constraints, implying that there are multiple
values of the vector θ which satisfy the constraints. An insufficient number of constraints may be identified
by a “rank deficiency” warning in numerical solvers of Eq. (A.8) [25]. Even if A has G2 rows, the system
may have an insufficient number of constraints because some constraints are redundant. In this situation,
we can pose the problem as a minimization problem, namely:
θ∗ = arg min f(θ), subject to: b = Aθ; θ ≥ 0 (A.18)
where f is a function which penalizes certain values of θ. For example, f = || · ||2 penalizes large values in
θ, so that the smallest values of eˆ and φ which satisfy the constraints will be resolved.4
Similarly, we may find that no solution exists for the given constraints, since two or more constraints are
in conflict. Conflicting constraints may be identified by a non-zero error in the solution to Eq. (A.8) [25].
In this case, the conflict should be resolved by changing or removing one of the conflicting constraints.
A.3. Previous Approaches
Few epidemic models of sexually transmitted infections with heterogeneity in risk have simulated turnover
among risk groups, and those models which have simulated turnover have done so in various ways. In this
section, we review three prior implementations of turnover and their assumptions. We then highlight how
the approach proposed in Section A.2 could be used to achieve the same objectives.
Stigum et al. [40] simulated turnover among G = 2 risk groups in a population with no exogenous entry
or exit (ν = µ = 0 and hence eˆ is not applicable). Turnover between the groups was balanced in order to
maintain constant risk group sizes (Type 1 constraint),5 while the rate of turnover from high to low was
specified as κ (Type 2 constraint). Thus, the turnover system used by Stigum et al. [40] can be written in
the proposed framework as: [
0
κ
]
=
[
xˆ1 −xˆ2
1 ·
] [
φ12
φ21
]
, eˆ1 = eˆ2 = 0 (A.19)
4 Numerical solutions to such problems are widely available, such as the Non-Negative Lease Squares solver [26], available in
Python: https://docs.scipy.org/doc/scipy/reference/generated/scipy.optimize.nnls.html.
5 Due to its simplicity, this constraint is actually an example of both Type 1 and Type 4 constraints.
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Henry and Koopman [18] also simulated turnover among G = 2 risk groups, but considered exogenous
entry and exit, both at a rate µ. The authors used the notation fi for our xˆi, and assumed that the
population of individuals entering into the modelled population had the same distribution of risk groups
as the modelled population itself: eˆi = fi (Type 2 constraint). The authors further maintained constant
risk group sizes (Type 1 constraint) by analytically balancing turnover between the two groups using:
φ12 = ωxˆ2; φ21 = ωxˆ1, where ω is a constant. However, it can be shown that this analytical approach is
also the solution to the following combination of Type 1 and Type 2 constraints:[
0
ωf2
]
=
[
f1 −f2
1 ·
] [
φ12
φ21
]
, eˆi = fi (A.20)
Eaton and Hallett [11] simulated turnover among G = 3 risk groups, considering a distribution of risk
among individuals entering into the modelled population eˆ which was different from xˆ. Turnover was
considered from high-to-medium, high-to-low, and medium-to-low risk, all with an equal rate ψ; the reverse
transition rates were set to zero (six total Type 2 constraints). Given the unidirectional turnover, risk group
sizes were maintained using the values of eˆi, computed using Type 1 constraints as follows: νx1 + 2x1ψνx2 − x1ψ + x2ψ
νx3 − x1ψ − x2ψ
 =
 ν · ·· ν ·
· · ν
 e1e2
e3
 , φ12 = φ13 = φ23 = ψ
φ21 = φ31 = φ32 = 0
(A.21)
In sum, the framework for modelling turnover presented in this section aims to generalize all previous
implementations. In so doing, we hope to clarify the requisite assumptions, dependencies on epidemiologic
data, and relationships between previous approaches.
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B. Supplemental Equations
Table B.1: Notation
Symbol Definition
i risk group index
j risk group index for “other” group in turnover
k risk group index for “other” group in incidence
t time
Si number of susceptible individuals in risk group i
Ii number of infectious individuals in risk group i
Ti number of treated individuals in risk group i
N total population size
ν rate of population entry
µ rate of population exit
φij rate of turnover from group i to group j
λi force of infection among susceptibles in risk group i
τ rate of treatment initiation among infected
xˆi proportion of individuals in risk group i
eˆi proportion of individuals entering into risk group i
δi average duration spent in risk group i
Ci number of partners per year among individuals in risk group i
β probability of transmission per partnership
ρik probability of partnership formation between risk groups i and k
B.1. Model Equations
d
dt
Si(t) = +
∑
j
φjiSj(t)−
∑
j
φijSi(t)− µSi(t) + νeˆiN(t)− λi(t)Si(t) (B.1a)
d
dt
Ii(t) = +
∑
j
φjiIj(t) −
∑
j
φijIi(t) − µIi(t) + λi(t)Si(t)− τIi(t) (B.1b)
d
dt
Ti(t) = +
∑
j
φjiTj(t) −
∑
j
φijTi(t) − µTi(t) + τIi(t) (B.1c)
︸ ︷︷ ︸
turnover into
︸ ︷︷ ︸
turnover from
︸ ︷︷ ︸
death
︸ ︷︷ ︸
birth
︸ ︷︷ ︸
incidence
︸ ︷︷ ︸
treatment
B.2. Complete Example Turnover System
constant group size

specified e

group duration

turnover rate ratios


νx1
νx2
νx3
e∗1
e∗2
e∗3
δ1
−1 − µ
δ2
−1 − µ
δ3
−1 − µ
0
0
0

=

ν · · −x1 −x1 x2 · x3 ·
· ν · x1 · −x2 −x2 · x3
· · ν · x1 · x2 −x3 −x3
1 · · · · · · · ·
· 1 · · · · · · ·
· · 1 · · · · · ·
· · · 1 1 · · · ·
· · · · · 1 1 · ·
· · · · · · · 1 1
· · · x1 · −x2 · · ·
· · · · x1 · · −x3 ·
· · · · · · x2 · −x3


e1
e2
e3
φ12
φ13
φ21
φ23
φ31
φ32

(B.2)
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B.3. Redundancy in specifying all elements of eˆ
Whenever it is assumed that risk groups do not change size, G rows of the form shown in Eq. (A.11) are
added to b and A:
b =
 νx1νx2
νx3
 ; A =
 ν · · −x1 −x1 x2 · x3 ·· ν · x1 · −x2 −x2 · x3
· · ν · x1 · x2 −x3 −x3
 (A.11)
After multiplying by θ, these G rows can be row-reduced by summing to obtain:
[νx1 + νx2 + νx3] = [νe1 + νe2 + νe3 + 0φ12 + 0φ13 + 0φ21 + 0φ23 + 0φ31 + 0φ32]
ν [x1 + x2 + x3] = ν [e1 + e2 + e3]
(B.3)
which therefore implies that
∑
i xi =
∑
i ei, or equivalently
∑
i xˆi =
∑
i eˆi = 1. Thus, it is redundant to
specify all G elements of eˆ, as the final element will be dictated by constant group size constraints.
B.4. Factors of Incidence
Substituting the proportional mixing definition of ρik into the incidence equation, Eq. (3), we have:
λi = Ci
∑
k
ρikβ
Ik
Xk
= Ciβ
∑
k
CkXk∑
k CkXk
Ik
Xk
= Ciβ
∑
k CkIk∑
k CkXk︸ ︷︷ ︸
f
(B.4)
We can factor the term f as:
f =
∑
k CkIk∑
k CkXk
=
∑
k CkIk∑
k Ik
·
∑
k Ik∑
k Xk
·
∑
k Xk∑
k CkXk
(B.5)
which we recognize as the following terms:
= CˆI · Iˆ · Cˆ−1 (B.6)
Namely,
1. CˆI is the average number of partners among infectious individuals
2. Iˆ is the proportion of the population who are infectious (overall prevalence)
3. Cˆ is the average number of partners among all individuals (constant)
Therefore, only two non-constant factors control incidence per susceptible: 1) the average number of partners
among infectious individuals CˆI , and 2) overall prevalence Iˆ. The product of these factors CˆI Iˆ, scaled by
β Ci/Cˆ, then gives λi. In fact, the incidence in each group individually is proportional to incidence overall,
as Ci is only factor depending on i.
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C. Supplemental Results
C.1. Equilibrium health states and rates of transition
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Figure C.1: Equilibrium health state proportions under different rates of turnover.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
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Figure C.2: Absolute rates of change at equilibrium (number of individuals gained/lost per year) among individuals in each
health state and risk group, broken down by type of change: gain via births, loss/gain via incident infections, loss/gain via
treatment, loss/gain via turnover, loss via death, and net change. Based on Eq. (B.1).
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03. Rates of
change do not sum to zero due to population growth.
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Figure C.3: Proportion of new infectious individuals in each risk group which are from turnover of infectious individuals, as
opposed to incident infection of susceptible individuals in the risk group.
C.2. Equilibrium Prevalence Ratios
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Figure C.4: Equilibrium prevalence ratios between risk groups under different rates of turnover.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
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C.3. Equilibrium Incidence
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(a) High risk
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(b) Medium risk
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Figure C.5: Equilibrium incidence among high, medium, and low risk groups under different rates of turnover.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03. Incidence
in each risk group is proportional to overall incidence with Ci as a scale factor.
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Figure C.6: Equilibrium incidence ratios between risk groups under different rates of turnover. Incidence ratios do not depend
on turnover.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
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C.4. Equilibrium prevalence and number of partners before and after model fitting
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(a) High risk
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Figure C.7: Equilibrium STI prevalence among high, medium, and low risk groups as well as overall, with and without turnover,
and with and without fitted Ci to group-specific prevalence.
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Figure C.8: Numbers of partners Ci among high, medium, and low risk groups as well as overall, with and without turnover,
and with and without model fitting to group-specific prevalence.
C.5. Influence of turnover on the tPAF of the highest risk group before model fitting
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Figure C.9: Transmission population attributable fraction (tPAF) of the high risk group in models with and without turnover,
before model fitting.
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C.6. Effect of treatment rate on the influence of turnover on equilibrium prevalence
In order to examine the effect of treatment rate τ on the results of Experiment 1 – the influence of turnover
on equilibrium prevalence – we recreated Figures 4 and 7 for a range of treatment rates τ ∈ [0.05, 1.0]. The
results are shown in Figure C.10.
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(b) Prevalence among medium risk
0.03 0.04 0.07 0.1 0.15 0.22 0.33
High risk turnover δ−1H
0.00
0.02
0.04
0.06
0.08
P
re
va
le
n
ce
am
on
g
lo
w
ri
sk
A B
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(d) Average C among infectious individuals CˆI
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(e) Prevalence overall
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Figure C.10: Relationship between turnover rate and equilibrium STI prevalence in high, medium, and low risk groups, as well
as overall STI prevalence and incidence, and average C among infectious individuals, for a range of treatment rates τ . Darker
blue indicates higher treatment rate. The threshold turnover rate separating regions A and B decreases with treatment rate,
meaning that increasing turnover becomes more likely to decrease equilibrium prevalence as treatment rate increases.
Turnover rate (log scale) is a function of the duration of time spent in the high risk group δH , where shorter time spent in the
high risk group yields faster turnover. No turnover is indicated by δ−1H = 0.03, due to population exit rate µ = 0.03.
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